Treatment Effectiveness and Side Effects: A Model of Physician Learning

Published Online:https://doi.org/10.1287/mnsc.1120.1640

References

  • Ackerberg D. Empirically distinguishing informative and prestige effects of advertising. RAND J. Econom. (2001) 32(2):316–333CrossrefGoogle Scholar
  • Berry S, Levinsohn J, Pakes A. Differentiated products demand systems from a combination of micro and macro data: The new vehicle market. J. Political Econom. (2004) 112(1):68–104CrossrefGoogle Scholar
  • Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S. Efficacy and safety of Tadalafil for the treatment of erectile dysfunction: Results of integrated analysis. J. Urology (2002) 168(4):1332–1336CrossrefGoogle Scholar
  • Chan T, Hamilton B. Learning, private information and the economic evaluation of randomized experiments. J. Political Econom. (2006) 115(6):997–1040CrossrefGoogle Scholar
  • Ching A. Consumer learning and heterogeneity: Dynamics of demand for prescription drugs after patent expiration. Internat. J. Indust. Organ. (2010) 28(6):619–638CrossrefGoogle Scholar
  • Ching A, Ishihara M. The effects of detailing on prescribing decisions under quality uncertainty. Qualitative Marketing Econom. (2010) 8(2):123–165CrossrefGoogle Scholar
  • Ching A, Ishihara M. Measuring the informative and persuasive roles of detailing on prescribing decisions. Management Sci. (2012) 58(7):1374–1387LinkGoogle Scholar
  • Chintagunta PK, Renna J, Ginger ZJ. Information, learning, and drug diffusion: The case of Cox-2 inhibitors. Quant. Marketing Econom. (2009) 7(4):399–443CrossrefGoogle Scholar
  • Crawford G, Shum M. Uncertainty and learning in pharmaceutical demand. Econometrica (2005) 73(4):1137–1174CrossrefGoogle Scholar
  • DeGroot MH. Optimal Statistical Decisions (1970) (McGraw-Hill, New York) Google Scholar
  • Dickstein MJ. Efficient provision of experience goods: Evidence from antidepressant choice. (2011) . Working paper, Stanford University, Stanford, CAGoogle Scholar
  • Doganoğlu T. Switching costs, experience goods and dynamic price competition. Quant. Marketing Econom. (2010) 8(2):167–205CrossrefGoogle Scholar
  • Erdem T, Keane M. Decision-making under uncertainty: Capturing dynamic brand choice process in turbulent consumer goods markets. Marketing Sci. (1996) 15(1):1–20LinkGoogle Scholar
  • Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral Sildenafil in the treatment of erectile dysfunction. New England J. Medicine (1998) 338(20):1397–1404CrossrefGoogle Scholar
  • Harris K, Keane M. A model of health plan choice: Inferring preferences and perceptions from a combination of revealed preference and attitudinal data. J. Econometrics (1999) 89(4):614–157Google Scholar
  • Hellstrom WJG, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H. Vardenafil for treatment of mean with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial. J. Andrology (2002) 23(6):763–771Google Scholar
  • Hurwitz MA, Caves RE. Persuasion or information? Promotion and the shares of brand name and generic pharmaceuticals. J. Law Econom. (1988) 31(2):299–320CrossrefGoogle Scholar
  • Klemperer P. Markets with consumer switching costs. Quart. J. Econom. (1987) 102(2):375–394CrossrefGoogle Scholar
  • Klemperer P. Welfare effects of entry into market with switching costs. J. Indust. Econom. (1988) 37(2):159–165CrossrefGoogle Scholar
  • Klemperer P. Multi-period competition with switching costs. Econometrica (1992) 60(3):651–666CrossrefGoogle Scholar
  • Klemperer P. Competition when consumers have switching costs: An overview with applications to industrial organization, macroeconomics, and international trade. Rev. Econom. Stud. (1995) 62(4):515–539CrossrefGoogle Scholar
  • Lasser K, Allen P, Woolhandler S, Himmelstein D, Wolfe S, Bor D. Timing of new black box warnings and withdrawals for prescription medications. J. Amer. Medical Assoc. (2002) 287(17):2215–2220CrossrefGoogle Scholar
  • Leffler KB. Persuasion or information? The economics of prescription drug advertising. J. Law Econom. (1981) 24(1):45–74CrossrefGoogle Scholar
  • Manchanda P, Rossi PE, Chintagunta PK. Response modeling with nonrandom marketing-mix variables. J. Marketing Res. (2004) 41(4):467–478CrossrefGoogle Scholar
  • Manchanda P, Xie Y, Youn N. The role of targeted communication and contagion in product adoption. Marketing Sci. (2008) 27(6):961–976LinkGoogle Scholar
  • Manski C. Measuring expectations. Econometrica (2004) 72(5):1329–1376CrossrefGoogle Scholar
  • Narayanan S, Manchanda P. Heterogeneous learning and the targeting of marketing communication for new products. Marketing Sci. (2009) 28(3):424–441LinkGoogle Scholar
  • Train K. Discrete Choice Methods with Simulation (2003) (Cambridge University Press, Cambridge, UK) CrossrefGoogle Scholar
  • Villas-Boas JM. Consumer learning, brand loyalty, and competition. Marketing Sci. (2004) 23(1):134–145LinkGoogle Scholar
  • Villas-Boas JM. Dynamic competition with experience goods. J. Econom. Management Strategy (2006) 15(1):37–66CrossrefGoogle Scholar
  • Villas-Boas JM, Winer RS. Endogeneity in brand choice models. Management Sci. (1999) 45(10):1324–1338LinkGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.